Michael Hodges
InvestorScientific Advisor at Adjuvant Capital · Entrepreneur in Residence at Claris Ventures
San Diego, California, United States
About
Entrepreneur in Residence and pharmaceutical physician with expertise in RNA therapeutics, infectious diseases and clinical development; supports scientific evaluation and portfolio strategy.
Experience
- RNA Medicines, LLCBiotechnology drug development consultant, scientific advisor and board membercurrent2014 — presentSan Diego, California, United States
- Claris VenturesEntrepreneur in Residencecurrent2025 — presentTurin, Piedmont, Italy
- Claris VenturesVenture Capital Partner2023 — 2025Turin, Piedmont, Italy
- Telesis BioBoard Membercurrent2024 — presentSan Diego, CA, USA
- Arcturus TherapeuticsScience Advisory Boardcurrent2014 — presentSan Diego, CA, USA
- Cerberus TherapeuticsScience Advisory Boardcurrent2024 — presentBoston, Massachusetts, United States
- Ochre BioScience Advisory Boardcurrent2022 — presentOxford, England, United Kingdom
- Adjuvant CapitalScientific Advisorcurrent2021 — presentNew York, New York, United States
- Memo Therapeutics AGScience Advisory Boardcurrent2023 — presentZurich, CH
- 1STRANDChief Executive Officercurrent2020 — presentSan Diego County, California, United States
- RiboX TherapeuticsScience Advisory Board2022 — 2025Boston, Massachusetts, United States
- AbVaccBoard Member2021 — 2024Washington, DC, United States
- Hybridize TherapeuticsStrategic Advisory Board2021 — 2024Leiden, South Holland, Netherlands
- eFFECTOR Therapeutics, Inc.Science Advisory Board2020 — 2024San Diego, California, United States
- Resalis TherapeuticsBoard Member2021 — 2024Milan, Lombardy, Italy
- Novo HoldingsScientific Advisor2021 — 2023
- Amplyx Pharmaceuticals, IncChief Medical Officer2016 — 2021San Diego
- Santaris Pharmaceuticals, A/SChief Medical Officer2010 — 2014Greater San Diego Area and Copenhagen, DK
- F2GNon Executive Director2010 — 2014Manchester, UK
- Altair Therapeutics, IncChief Medical Officer2008 — 2010Greater San Diego Area
- Kemia, Inc.Chief Medical Officer2007 — 2008Greater San Diego Area
- Pfizer Global Research and DevelopmentDrug Development1990 — 2007Sandwich, UK; Groton/New London CT, USA; La Jolla, CA, USA
Skills & more
Seed CapitalEarly Stage InvestmentStartup EnvironmentsOperations ManagementBoard LevelTherapeutic Areas10Drug Development42Pharmaceutical Industry39Clinical Trials30Biotechnology28Pharmacology11Infectious Diseases17
+12 more
OncologyRegulatory SubmissionsClinical Study DesignTranslational MedicineMedicineCancerBiopharmaceuticalsLife SciencesLifesciencesINDPatentsClinical DevelopmentFrom Michael's professional profile.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Glenn Rockman
Co-Founder and Partner at Adjuvant Capital
Frequently asked questions
- Who is Michael Hodges?
- Entrepreneur in Residence and pharmaceutical physician with expertise in RNA therapeutics, infectious diseases and clinical development; supports scientific evaluation and portfolio strategy.
- Where does Michael Hodges work?
- Michael Hodges is Scientific Advisor at Adjuvant Capital.
- Where did Michael Hodges go to school?
- Michael Hodges studied at Westminster Medical School, University of London (MB BS, Medicine); King's College London (Bachelor of Science - BS, Pharmacology).
Same school
Also attended King's College London284
Harry StebbingsFounder & General Partner at 20VCDominic JacquessonInvestor at Index VenturesJohn HortonInvestor at DN CapitalBob ThomasPartner at OxxKatherineHealthcare Investment Lead at Hummingbird VenturesÖzge Gizem YerlikayaGeneral Counsel at Idacapital
+ 278 more
Shared employers
Also worked at Claris Ventures11
Pietro PuglisiManaging Partner at Claris VenturesCiro SpedaliereManaging Partner at Claris VenturesPaolo VigoSenior Associate at Claris VenturesGiuditta MagnificoSenior Analyst at Claris VenturesGiulia VestriPartner at Claris VenturesGianmarco PallaviciniSenior Associate at Claris Ventures
+ 5 more
Also worked at Memo Therapeutics AG8
Thomas HarthPartner at Ysios CapitalMaría Vega de SeoaneController at Ysios CapitalLaura ArgelichAssociate at Ysios CapitalMichael SidlerFounding Partner at redalpineHadrien BouchezPartner at Kurma PartnersButrint AliuAnalyst at Pureos Bioventures
+ 2 more
Also worked at Hybridize Therapeutics2
Also worked at Novo Holdings46
Jeffrey LowPartner at Averin CapitalRodrigo SantosEntrepreneur in Residence at Cambridge Innovation CapitalSarah HubnerJr. Executive Assistant at Level EquityStephan ChristgauFounding Partner at EIR VenturesHaitao HuData Analyst at Linear CapitalFederico MüllerVenture Partner at Tantauco
+ 40 more


























.avif)

















